| 1. Daly C, Eichten A, Castanaro C, Pasnikowski E, Adler A, Lalani AS, Papadopoulos N, Kyle AH, Minchinton AI, Yancopoulos GD et al.. (2013) Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.. Cancer Res, 73 (1): (108-18). [PMID:23149917] |
| 2. Gerald D, Chintharlapalli S, Augustin HG, Benjamin LE. (2013) Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy.. Cancer Res, 73 (6): (1649-57). [PMID:23467610] |
| 3. Regula JT, Lundh von Leithner P, Foxton R, Barathi VA, Cheung CM, Bo Tun SB, Wey YS, Iwata D, Dostalek M, Moelleken J et al.. (2016) Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.. EMBO Mol Med, 8 (11): (1265-1288). [PMID:27742718] |
| 4. Maisonpierre, P C PC and 13 more authors.. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.. Science (New York, N.Y.), (4): [PMID:9204896] |
| 5. Tanaka, S S and 5 more authors.. (1999) Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma.. The Journal of clinical investigation, [PMID:9927494] |
| 6. Kim, I I and 5 more authors.. (2000) Characterization and expression of a novel alternatively spliced human angiopoietin-2.. The Journal of biological chemistry, (16): [PMID:10766762] |
| 7. Fiedler, Ulrike U and 8 more authors.. (2003) Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats.. The Journal of biological chemistry, (17): [PMID:12427764] |
| 8. Lee, Hyuek Jong HJ and 9 more authors.. (2004) Biological characterization of angiopoietin-3 and angiopoietin-4.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, [PMID:15284220] |
| 9. Barton, William A WA, Tzvetkova, Dorothea D and Nikolov, Dimitar B DB.. (2005) Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition.. Structure (London, England : 1993), [PMID:15893672] |
| 10. Nusbaum, Chad C and 75 more authors.. (2006) DNA sequence and analysis of human chromosome 8.. Nature, (19): [PMID:16421571] |
| 11. Barton, William A WA and 6 more authors.. (2006) Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex.. Nature structural & molecular biology, [PMID:16732286] |
| 12. Yacyshyn, Orisha K OK and 5 more authors.. (2009) Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells.. Angiogenesis, [PMID:19116766] |
| 13. Yuan, Hai Tao HT, Khankin, Eliyahu V EV, Karumanchi, S Ananth SA and Parikh, Samir M SM.. (2009) Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium.. Molecular and cellular biology, [PMID:19223473] |
| 14. Leppänen, Veli-Matti and 20 more authors.. (2020) Characterization of ANGPT2 mutations associated with primary lymphedema.. Science translational medicine, (9): [PMID:32908006] |
ZJ24F0303687